SCHEMBL523193

SCHEMBL523193

CC(C)=CC1C(C(=O)OCc2ccccc2)C1(C)C

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.76
LMNA P02545 4/20 0.62
ADRA2A P08913 1/20 0.62
CNR1 P21554 1/20 0.62
ATM Q13315 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
CYP1A2 P05177 3/20 0.53
CYP2C19 P33261 3/20 0.53
TSHR P16473 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
FABP7 O15540 1/20 0.43
FABP5 Q01469 1/20 0.43
TRPV1 Q8NER1 1/20 0.42
ELANE P08246 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6054983 0.90 TDP1 (0.81) TDP1LMNAADRA2ACNR1ATM
SCHEMBL1074157 0.89 TDP1 (0.63) TDP1LMNAADRA2ACNR1ATM
SCHEMBL1074161 0.89 TDP1 (0.63) TDP1LMNAADRA2ACNR1ATM
SCHEMBL10983065 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL11072467 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL30603080 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL22931582 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL4433240 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL4433235 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM
SCHEMBL4433243 0.89 TDP1 (0.76) TDP1LMNAADRA2ACNR1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4788323-A Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-11-29 US claimed
US-4659864-A USING ALUMINUM BORMIDE AND A HYDROPEROXIDE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1987-04-21 US claimed
CN-114456164-B Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents 先正达参股股份有限公司 2024-03-12 CN disclosed
EP-2415741-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-02-08 EP disclosed
US-20120029195-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed
US-20120010417-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-12 US disclosed
EP-1797953-B1 PROCESS FOR PRODUCING OXYGENIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2011-01-05 EP disclosed
US-20080064898-A1 Method for Producing Oxygen-Containing Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-13 US disclosed
EP-1463706-B1 PROCESS FOR PRODUCTION OF 3,3-DIMETHYL-2-FORMYLCYCLOPROPANECARBOXYLIC ACID DERIVATIVES SUMITOMO CHEMICAL CO (JP) 2008-02-27 EP disclosed
US-7276622-B2 Method for producing oxygen-containing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-02 US disclosed
US-7262320-B2 Process for production of 3,3-dimethyl-2-formylcyclopropanecarboxylic acid derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-08-28 US disclosed
US-4820864-A Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-04-11 US disclosed
EP-0299760-A1 Method for racemization of optically active chrysanthemic acid or its derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-01-18 EP disclosed
US-4788323-A Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-11-29 US disclosed
EP-0282221-A2 Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-09-14 EP disclosed
EP-0261824-A1 Method for racemization of optically active chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-03-30 EP disclosed
US-4723035-A Method for racemization of chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-02-02 US disclosed
EP-0235940-A1 Method for racemization of chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-09-09 EP disclosed
US-4659864-A USING ALUMINUM BORMIDE AND A HYDROPEROXIDE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1987-04-21 US disclosed
EP-0165070-A2 Method for racemization of chrysanthemic acid or its ester SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064898-A1 Method for Producing Oxygen-Containing Compound AOC2, AOX1, CAT TDP1 4391/4885LMNA 3622/4885ADRA2A 3643/4885
US-20120010417-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 TDP1 3832/4885LMNA 3279/4885ADRA2A 1934/4885
US-20120029195-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR ADH1A, ADH1C, ADH5 TDP1 3331/4885LMNA 4306/4885ADRA2A 3144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.